ClinicalTrials.gg
CompletedNCT04766658Updated Oct 19, 2022

A Study to Evaluate Effects of Gargle Phonation in Voice

An interventional study of Gargle Phonation and Water swallow in Voice Disorders, Muscle Tension Dysphonia and Speech Therapy, sponsored by Mayo Clinic. Completed at 2 sites in United States. Open to participants aged 18 Years to 89 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-10-19.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
All
01

Study summary

The purpose of this study is to assess subjects with muscle tension dysphonia for perceived effort and acoustic effects of gargle phonation compared to baseline and a sham water swallow.

Read the detailed description

This study assesses perceived effort following baseline talking, water swallows and gargle phonation. In addition to perceived effort, acoustic and perceptual analyses will be conducted on the recorded voice samples using vowel sounds, the Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) and Hearing in Noise Sentences (HINT).

02

Conditions studied

  • Voice Disorders
  • Muscle Tension Dysphonia
  • Speech Therapy
03

In context

Voice Disorders

77 studies on the registry are indexed under Voice Disorders; 17 are open to participants now.

This study's enrollment of 36 is below the median of 41 across 54 interventional studies indexed under Voice Disorders.

Browse Voice Disorders studies →

Lead sponsor

Mayo Clinic is the lead sponsor of 3,269 studies on the registry; 672 are open to participants now.

Of its 452 completed or terminated interventional studies of FDA-regulated products, 321 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients must have a primary or secondary muscle tension dysphonia based clinical assessment with a Mayo clinic speech language pathologist or other Mayo Clinic otolaryngology care provider in Rochester or Phoenix/Scottsdale locations.
  • Age 18 through 89.
  • Able to provide .

Exclusion criteria

Exclusion Criteria:

  • Anyone not meeting inclusion criteria.
  • Anyone unable or unwilling to provide .
  • Anyone unable to complete questionnaires or participate in voice recording.
  • Anyone with severe neurological voice or speech disorders.
  • Moderate or severe dysphagia for thin liquids.
  • Non-English speakers (English as a second language may be included).
  • Extensive laryngeal surgery or other surgery or medical condition that may significantly alter the motor or sensory aspects of the larynx.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Other
    Water Swallow Intervention First

    Subjects will complete voice recordings after water swallows and then perform voice recordings after gargle phonation.

    Other: Water swallow

  • Other
    Gargle Phonation Intervention First

    Subjects will complete voice recordings after gargle phonation and then perform voice recordings after gargle phonation.

    Other: Gargle Phonation

Interventions

  • OtherGargle Phonation

    Subjects will gargle water while making sound

  • OtherWater swallow

    Subjects will hold water in their mouth for 5 seconds and swallow

06

What researchers measure

Primary outcomes

  1. Rating of Effort Baseline

    Measured using patient self-reported Borg effort scale where 0=no vocal effort and 10=maximum vocal effort.

    Time frame: Baseline

  2. Rating of Effort Post Swallow

    Measured using patient self-reported Borg effort scale where 0=no vocal effort and 10=maximum vocal effort.

    Time frame: After water swallow intervention, approximately 5 minutes

  3. Rating of Effort Post Gargle

    Measured using patient self-reported Borg effort scale where 0=no vocal effort and 10=maximum vocal effort.

    Time frame: After gargle phonation intervention, approximately 5 minutes

07

Study locations

2 sites
  • Mayo Clinic in Arizona
    Scottsdale, Arizona 85259, United States
  • Mayo Clinic in Rochester
    Rochester, Minnesota 55905, United States
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2021 to primary completion in Apr 2021, 2 months.

Of 30 interventional studies with no phase under Voice Disorders, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 48. This study's 2 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 29, 2021
First posted
Feb 23, 2021
StartActual
Jan 29, 2021
Primary completionActual
Apr 15, 2021
CompletionActual
Apr 15, 2021
Last update
Oct 19, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 19, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04766658
Lead sponsor
Mayo Clinic
Responsible party
Diana M. Orbelo (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Feb 23, 2021
Start date
Jan 29, 2021
Primary completion
Apr 15, 2021
Completion
Apr 15, 2021
Last update
Oct 19, 2022

Study contacts

Diana M Orbelo, PhD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion